Metenolone

Metenolone

Clinical data
ATC code	A14AA04 (WHO)
Identifiers
IUPAC name 17-Hydroxy-1,10,13-trimethyl-4,5,6,7,8,9,10,11,12,13, 14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
CAS Number	153-00-4
PubChem CID	9054
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H30O2
Molar mass	302.451 g/mol

WikiDoc Resources for Metenolone
Articles
Most recent articles on Metenolone Most cited articles on Metenolone Review articles on Metenolone Articles on Metenolone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Metenolone Images of Metenolone Photos of Metenolone Podcasts & MP3s on Metenolone Videos on Metenolone
Evidence Based Medicine
Cochrane Collaboration on Metenolone Bandolier on Metenolone TRIP on Metenolone
Clinical Trials
Ongoing Trials on Metenolone at Clinical Trials.gov Trial results on Metenolone Clinical Trials on Metenolone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Metenolone NICE Guidance on Metenolone NHS PRODIGY Guidance FDA on Metenolone CDC on Metenolone
Books
Books on Metenolone
News
Metenolone in the news Be alerted to news on Metenolone News trends on Metenolone
Commentary
Blogs on Metenolone
Definitions
Definitions of Metenolone
Patient Resources / Community
Patient resources on Metenolone Discussion groups on Metenolone Patient Handouts on Metenolone Directions to Hospitals Treating Metenolone Risk calculators and risk factors for Metenolone
Healthcare Provider Resources
Symptoms of Metenolone Causes & Risk Factors for Metenolone Diagnostic studies for Metenolone Treatment of Metenolone
Continuing Medical Education (CME)
CME Programs on Metenolone
International
Metenolone en Espanol Metenolone en Francais
Business
Metenolone in the Marketplace Patents on Metenolone
Experimental / Informatics
List of terms related to Metenolone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Metenolone (or methenolone) is a long-acting anabolic steroid with weak androgenic (testosterone or androsterone-like) properties. It is a naturally occurring drug, found within the adrenal glands of pregnant domesticated felines, and is supplied as the acetate ester for oral administration and as the enanthate ester for intramuscular injection. Adult doses for the treatment of aplastic anemia are usually in a range of 1–3 mg/kg per day.

Side effects

Adverse side effects include fluid and electrolyte retention, hypercalcaemia, increased bone growth and skeletal weight. In men, additional side priapism, azoospermia, hirsutism, male pattern baldness, acne and oedema. In women, side effects include virilization, amenorrhoea, menstrual irregularities, suppressed lactation, and increased libido. In children, side effects may include virilization symptoms. Metenolone may enhance effects of antidiabetics, ciclosporin, levothyroxine, warfarin. Resistance to the effects of neuromuscular blockers may occur, and metenolone also has the potential to interfere with glucose tolerance and thyroid function tests.

Use in sports

As an anabolic steroid, the use of metenolone is banned from use in sports governed by the World Anti-Doping Agency. Belarusian shot putter Nadzeya Ostapchuk was stripped of her gold medal after testing positive for metenolone at the London 2012 Olympic Games. She has been excluded from future IOC events.

The NBA and NBPA also banned the use of methenolone under the Anti-Drug Program. In February 2013, Hedo Türkoğlu of the Orlando Magic was suspended for 20 games without pay by the league after testing positive for methenolone.

In December 2013, Natalia Volgina was stripped of her 2013 Old Mutual Two Oceans Marathon title and received a two-year competition ban, subsequent to a final guilty verdict for using the steroid Metenolone.